Research programme: neuraminidase inhibitor - TaiMed Biologics

Drug Profile

Research programme: neuraminidase inhibitor - TaiMed Biologics

Alternative Names: Tamiphosphor; TMB-571

Latest Information Update: 09 Oct 2015

Price : $50

At a glance

  • Originator Academia Sinica
  • Developer TaiMed Biologics
  • Class Small molecules
  • Mechanism of Action Neuraminidase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Influenza virus infections

Most Recent Events

  • 09 Oct 2015 Preclinical development is ongoing in USA
  • 28 Dec 2008 Preclinical trials in Influenza virus infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top